abnormal cell-mediated immunity_Plau<tm1Mlg>/Plau<tm1Mlg>

http://metadb.riken.jp/0002421I129S2SvPasC57BL6Plautm1MlgPlautm1MlgPlautm1Mlg

abnormal cell-mediated immunity_Plau<tm1Mlg>/Plau<tm1Mlg>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• plasminogen activator, urokinase
  http://metadb.riken.jp/db/mgi_rdf/MGI:97611

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Plau<tm1Mlg>/Plau<tm1Mlg>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Plau<tm1Mlg>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S2/SvPas * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal cell-mediated immunity
  http://purl.obolibrary.org/obo/MP_0002421

文献

http://purl.org/net/cito/citesAsAuthority

• Margaret R. Gyetko, et.al., Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection., Journal of immunology (Baltimore, Md. : 1950), 2002, 168
  http://rdf.ncbi.nlm.nih.gov/pubmed/11777975
• Margaret R. Gyetko, et.al., Urokinase-deficient mice fail to generate a type 2 immune response following schistosomal antigen challenge., Infection and immunity, 2004, 72
  http://rdf.ncbi.nlm.nih.gov/pubmed/14688127